Zobrazeno 1 - 10
of 25
pro vyhledávání: '"M. E. Pochtar'"'
Autor:
M. A. Granatkin, E. A. Nikitin, M. I. Kislova, E. S. Mikhailov, V. A. Doronin, S. V. Minenko, M. M. Okuneva, A. V. Antonova, N. V. Degtyareva, M. E. Pochtar, S. A. Lugovskaya, Yu. N. Kobzev, V. V. Ptushkin, E. V. Rimashevskaya
Publikováno v:
Онкогематология, Vol 18, Iss 1, Pp 12-19 (2023)
Background. Treatment results in patients with relapsed and refractory acute myeloid leukemia (AML) remain unsatis‑factory. Treatment options for these patients are limited.Aim. To retrospectively analyze the efficacy and safety of combined therapy
Externí odkaz:
https://doaj.org/article/ef278213eaf0426fb5eff65766f77a94
Publikováno v:
Rossijskij Vestnik Perinatologii i Pediatrii, Vol 66, Iss 5, Pp 75-81 (2021)
Objective. To determine clinical course and state of cellular immunity in young children with rotavirus infection.Children characteristics and research methods. The scientists examined children without infectious pathology and with rotavirus infectio
Externí odkaz:
https://doaj.org/article/06feeb842db241b3b22a805c9e14f97d
Autor:
A. N. Os'kin, S. G. Gorbunov, L. N. Mazankova, S. A. Lugovskaya, E. V. Naumova, M. E. Pochtar'
Publikováno v:
Журнал инфектологии, Vol 13, Iss 3, Pp 46-54 (2021)
Purpose: to improve the complex therapy of rotavirus infection in infants by including interferon and to evaluate its clinical and immunological effectiveness.Materials and methods. Infants without infectious pathology and with rotavirus infection, w
Externí odkaz:
https://doaj.org/article/fc31fd46dea44337bba92f923f467737
Autor:
E. E. Markova, E. A. Nikitin, E. A. Dmitrieva, S. Yu. Mayorоva, Yu. B. Kochkareva, E. V. Naumova, S. A. Lugovskaya, M. E. Pochtar, А. А. Petrenko, М. I. Kislova, B. V. Biderman, А. B. Sudarikov, Т. N. Obukhova, V. V. Ptushkin
Publikováno v:
Russian journal of hematology and transfusiology. 67:478-490
Introduction. Optimal therapy for elderly patients with chronic lymphocytic leukemia (CLL) is the subject of intensive research.Aim – to study the safety of obinutuzumab, as well as the selection of the optimal scheme of its use in patients with CL
Autor:
A. M. Popov, T. U. Verzhbitskaya, E. E. Zueva, O. V. Anan’eva, E. V. Babenko, L. V. Baydun, E. A. Belyakova, E. V. Boyakova, O. G. Bortnikova, M. V. Gorchakova, L. Yu. Grivtsova, E. N. Grinkevich, Yu. V. Davydova, E. I. Zakhar’ko, O. I. Illarionova, N. M. Kaprano, E. A. Koroleva, S. A. Kochengina, E. G. Kuz’mina, E. A. Kustova, T. A. Makarova, Yu. V. Mirolyubova, O. E. Murashkina, T. Yu. Mushkarina, E. S. Nisheva, I. A. Novikova, E. Yu. Osipova, G. E. Pluzhnikova, M. E. Pochtar, N. V. Pronkina, E. V. Rusanova, E. B. Rybkina, O. V. Seliverstova, N. N. Tupitsin, G. I. Uleyskaya, N. T. Urazalieva, L. G. Fechina, O. V. Khoroshikh, O. E. Tsareva, L. A. Shchekina, S. A. Plyasunova, S. A. Lugovskaya
Publikováno v:
Онкогематология, Vol 11, Iss 3, Pp 68-75 (2016)
Comparison of interpretation of acute lymphoblastic leukemia (ALL) flow cytometric diagnostics data was the aim of the study. Immunophenotyping data obtained from 10 patients with ALL were analysed separately in 26 laboratories from Russian Federatio
Externí odkaz:
https://doaj.org/article/bc25e5d62d554850b622e9652ee96523
Autor:
Alexander Popov, N. M. Kaprano, L. V. Baydun, G. E. Pluzhnikova, T.Yu. Mushkarina, E. E. Zueva, E. I. Zakhar’ko, SA Lugovskaya, S. A. Plyasunova, N. T. Urazalieva, L. A. Shchekina, O. V. Khoroshikh, E.G. Kuzmina, O. V. Seliverstova, T. A. Makarova, O. G. Bortnikova, M. E. Pochtar, L. G. Fechina, G. I. Uleyskaya, E. A. Koroleva, O. V. Anan’eva, E. A. Kustova, E. B. Rybkina, E. V. Babenko, E. S. Nisheva, E. V. Boyakova, E. A. Belyakova, L. Yu. Grivtsova, M. V. Gorchakova, Yu. V. Mirolyubova, E. N. Grinkevich, Yu. V. Davydova, O. E. Murashkina, Olga Illarionova, I. A. Novikova, E. Yu. Osipova, S. A. Kochengina, N. V. Pronkina, N. N. Tupitsin, O. E. Tsareva, E. V. Rusanova, T. U. Verzhbitskaya
Publikováno v:
Onkogematologiâ, Vol 11, Iss 3, Pp 68-75 (2016)
Comparison of interpretation of acute lymphoblastic leukemia (ALL) flow cytometric diagnostics data was the aim of the study. Immunophenotyping data obtained from 10 patients with ALL were analysed separately in 26 laboratories from Russian Federatio
Autor:
A I, Mininkova, S A, Lugovskaya, M E, Pochtar, N K, Khuazheva, A A, Tlevtsezheva, V I, Vorobiev, I S, Lavrentiev, E B, Emeliyanova, V V, Dolgov
Publikováno v:
Klinicheskaia laboratornaia diagnostika. 63(4)
The leukemia is a neoplastic clonal disease of hematopoietic system with primary affection of bone marrow. The modern technologies of automated blood analysis permit to implement a quick primary screening of pathological samples of blood suspicious f
Autor:
S. A. Lugovskaya, A. I. Mininkova, V. V. Dolgov, M. E. Pochtar, V. I. Vorob'ev, O. A. Gajiyeva, N. K. Huazheva
Publikováno v:
Laboratornaya sluzhba. 7:32
Publikováno v:
Klinicheskaia laboratornaia diagnostika. 59(11)
The achievement of molecular remission is associated with increasing of survival of patients with chronic lymphatic leukemia. The important direction of research is seeking of parameters applicable to forecast of response to therapy. The purpose of t
Publikováno v:
Klinicheskaia laboratornaia diagnostika. (10)